NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/26/2024
Back to search
Official data from USPTO
PEERSPECTIVESINPSORIASIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PEERSPECTIVESINPSORIASIS
ST13
US500000097365016Class
44
Filing
97365016
Registration
7340688
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
03/26/2024
Trademark type
Word
Nice classes
44
Filing date
04/15/2022
Registration date
03/26/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/26/2024
Last transaction
03/26/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/20/2023
First use in commerce
10/20/2023
Drawing code
4
Owner type
99
Owner location
Brussels, BE
Examiner
MURRAY, GEORGE
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
UCB Biopharma SRL
Representatives
Kumiko Ide WENDEROTH, LIND & PONACK, L.L.P.
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Providing medical information in the field of immunology diseases
Publications
History of USPTO decisions and trademark events.
23 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/26/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/22/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/21/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/21/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/21/2024
IUAF
USE AMENDMENT FILED
01/29/2024
EISU
TEAS STATEMENT OF USE RECEIVED
01/29/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/23/2023
EX1G
SOU EXTENSION 1 GRANTED
08/21/2023
EXT1
SOU EXTENSION 1 FILED
08/21/2023
EEXT
SOU TEAS EXTENSION RECEIVED
08/21/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/21/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/27/2022
PUBO
PUBLISHED FOR OPPOSITION
12/27/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/07/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/18/2022
DOCK
ASSIGNED TO EXAMINER
11/16/2022
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
05/02/2022
ALIE
ASSIGNED TO LIE
05/02/2022
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
04/27/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/20/2022
NWAP
NEW APPLICATION ENTERED
04/19/2022
Continuous trademark protection
Get notified about every new filing that threatens PEERSPECTIVESINPSORIASIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.